Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis

NCT03355573 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT03355573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03355573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis
Lead sponsor
UCB Biopharma SRL
Phase
Phase 2
Overall status
Completed
Start date
November 28, 2017
Completion date
October 19, 2022
Enrollment
255 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis